Event Details
January 01, 2019
Description
Khiron Life Sciences entered an MOU with Dayacann.
Participants (2)
| Name | Type | Mentions | |
|---|---|---|---|
| Khiron Life Sciences Corp | organization | 8 | View Entity |
| ACA | organization | 243 | View Entity |
Source Documents (1)
HOUSE_OVERSIGHT_024900.jpg
This document is page 84 of a Cowen Collaborative Insights market research report dated February 25, 2019. It details the legal and business landscape of the medical cannabis industry in Chile and Colombia, listing various companies involved such as Dayacann, Tilray, and Canopy Growth. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was gathered as part of a congressional investigation, likely related to financial records or investment bank communications.
Related Events
Events with shared participants
Khiron recognized first sales
2018-10-01 • Latin America
A new kind of festival dedicated to the philosophy of being the change you want to see.
Date unknown • Unknown
Publication of findings regarding hippocampus atrophy and walking benefits
2011-02-13 • N/A
Launch of the China-US Joint Research Center for Ecosystem and Environmental Change.
2006-01-01 • Knoxville, Tennessee
Khiron acquires NettaGrowth International Inc.
2019-01-01 • Uruguay
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event